R1 rectal resection: Look up and don't look down

Annals of Surgery

Volumn 260, Issue 5, 2014, Pages 794-800

  Tilly, Camille ^a   Lefèvre, Jérémie H ^a   Svrcek, Magali ^b   Shields, Conor ^a   Fléjou, Jean Francois ^b   Tiret, Emmanuel ^a   Parc, Yann ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Prognosis; Radiochemotherapy; Rectal cancer; Recurrence; Resection margin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION ENTEROPATHY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; RECTUM RESECTION; RETROSPECTIVE STUDY; ABDOMINAL SURGERY; ADENOCARCINOMA; ADJUVANT THERAPY; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECTAL NEOPLASMS; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE;

ADENOCARCINOMA; CASE-CONTROL STUDIES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84926127577     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000988     Document Type: Conference Paper

References (21)

1. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479-1482.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl JMed. 2001;345:638-646.
3. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575-582.
4. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999.
5. Bennis M, Parc Y, Lefevre JH, et al. Morbidity risk factors after low anterior resection with total mesorectal excision and coloanal anastomosis: A retrospective series of 483 patients. Ann Surg. 2012;255:504-510.
6. Tranchart H, Lefevre JH, Svrcek M, et al. What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer? Ann Surg Oncol. 2013;20:1551-1559.
7. Bretagnol F, Panis Y, Rullier E, et al. Rectal cancer surgery with or without bowel preparation: The French GRECCAR III multicenter single-blinded randomized trial. Ann Surg. 2010;252:863-868.
8. Park JH, Kim HC, Cho YK, et al. Narrow distal resection margin may be sufficient for rectal cancer after chemoradiation. Hepatogastroenterology. 2011;58:769-774.
9. Rutkowski A, Nowacki MP, Chwalinski M, et al. Acceptance of a 5-mm distal bowel resectionmargin for rectal cancer: is it safe? Colorectal Dis. 2012;14:71- 78.
10. Bujko K, Rutkowski A, Chang GJ, et al. Is the 1-cm Rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol. 2012;19:801-808.
11. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002;26:350-357.
12. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89:327-334.
13. Luna-Perez P, Bustos-Cholico E, Alvarado I, et al. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J Surg Oncol. 2005;90:20-25.
14. Khani MH, Smedh K, Kraaz W. Is the circumferential resection margin a predictor of local recurrence after preoperative radiotherapy and optimal surgery for rectal carcinoma? Colorectal Dis. 2007;9:706-712.
15. Lefevre JH, Amiot A, Joly F, et al. Risk of recurrence after surgery for chronic radiation enteritis. Br J Surg. 2011;98:1792-1797.
16. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114-1123.
17. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620-4625.
18. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
19. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet. 2009;373:811-820.
20. Tan KK, Lopes Gde L, Jr, Sim R. How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg. 2009;13:642-648.
21. Gonzalez M, Poncet A, Combescure C, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: A systematic review and meta-analysis. Ann Surg Oncol. 2013;20:572-579.